# Short antimicrobial peptides as cosmetic ingredients to deter dermatological pathogens

**Authors:** Mohammad Rahnamaeian, Andreas Vilcinskas

PMC · DOI: 10.1007/s00253-015-6926-1 · Applied Microbiology and Biotechnology · 2015-08-26

## TL;DR

Short antimicrobial peptides are promising for cosmetics to fight skin pathogens due to their effectiveness and ease of production.

## Contribution

The paper highlights the potential of short AMPs without disulfide bonds for cosmetic use against dermatological pathogens.

## Key findings

- Short AMPs are ideal for topical formulations due to their antimicrobial activity and low production costs.
- AMPs have shown proof-of-concept in clinical trials as anti-infectives for dermatological applications.
- Challenges remain in ensuring stability and specificity for prophylactic use in personal care products.

## Abstract

Antimicrobial peptides (AMPs) are components of the innate immune system in many species of animals. Their diverse spectrum of activity against microbial pathogens, both as innate defense molecules and immunomodulators, makes them attractive candidates for the development of a new generation of antibiotics. Although the potential immunogenicity of AMPs means they are not suitable for injection and their susceptibility to digestive peptidases is likely to reduce their oral efficacy, they are ideal for topical formulations such as lotions, creams, shampoos, and wound dressings and could therefore be valuable products for the cosmetic industry. In this context, short AMPs (<20 amino acids) lacking disulfide bonds combine optimal antimicrobial activity with inexpensive chemical synthesis and are therefore more compatible with large-scale production and the modifications required to ensure stability, low toxicity, and microbial specificity. Proof-of-concept for the application of AMPs as novel anti-infectives has already been provided in clinical trials. This perspective considers the anti-infective properties of short AMPs lacking disulfide bonds, which are active against dermatologically important microflora. We consider the challenges that need to be addressed to facilitate the prophylactic application of AMPs in personal care products.

## Full-text entities

- **Genes:** CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, DEFB4A (defensin beta 4A) [NCBI Gene 1673] {aka BD-2, DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2}
- **Diseases:** allergies (MESH:D004342), cancer (MESH:D009369), oral mucositis (MESH:D013280), Malassezia furfur (MESH:D014010), nail and skin diseases (MESH:D009260), tinea cruris (MESH:D000084002), atopic eczema (MESH:D003876), hemolysis (MESH:D006461), Dermatophytosis (MESH:D014005), itch (MESH:D011537), tinea pedi (MESH:D014008), Folliculitis (MESH:D005499), cytotoxic (MESH:D064420), otitis media (MESH:D010033), Skin pathogens (MESH:D012871), inflammatory (MESH:D007249), Onychomycosis (MESH:D014009), Seborrheic dermatitis (MESH:D012628), necrotic tissue (MESH:D017695), eczema (MESH:D004485), Dermatological diseases (MESH:D000168), fungal (MESH:D009181), -infectives (MESH:D007239)
- **Chemicals:** Epinecidin-8 (-), itraconazole (MESH:D017964), Isepamicin (MESH:C016927), Ranalexin (MESH:C086618), linezolid (MESH:D000069349), methicillin (MESH:D008712), cefotaxime (MESH:D002439), peptide (MESH:D010455), Cryptocandin (MESH:C122176), saturated fatty acids (MESH:D005227), fluconazole (MESH:D015725), ketoconazole (MESH:D007654), Stylisin 2 (MESH:C557536), ampicillin (MESH:D000667), disulfide (MESH:D004220), lipopeptide (MESH:D055666), homoTyrosine (MESH:C000711887), chloramphenicol (MESH:D002701), streptomycin (MESH:D013307), Ornithine (MESH:D009952), daptomycin (MESH:D017576), P5 (MESH:C016883), echinocandin (MESH:D054714), kanamycin (MESH:D007612), Penetratin (MESH:C414409), lysine (MESH:D008239), Metal (MESH:D008670), Metallocene (MESH:C013108), Ir (MESH:D007495), Os (MESH:D009992), calcium (MESH:D002118), vancomycin (MESH:D014640), lucimycin (MESH:D008155), amino acids (MESH:D000596), azole (MESH:D001393), Ru (MESH:D012428), AMP (MESH:D000089882),  (MESH:D023181),  (MESH:D003358)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Colletotrichum sp. (species) [taxon 34409], Homo sapiens (human, species) [taxon 9606], Trichosporon beigelii (species) [taxon 5553], Microsporum audouinii (species) [taxon 34393], Bacillus licheniformis (species) [taxon 1402], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Malassezia restricta (species) [taxon 76775], Pardachirus marmoratus (finless sole, species) [taxon 31087], Mucor mucedo (species) [taxon 29922], Drosophila melanogaster (fruit fly, species) [taxon 7227], Human immunodeficiency virus 1 (no rank) [taxon 11676], Tityus serrulatus (Brazilian scorpion, species) [taxon 6887], Malassezia slooffiae (species) [taxon 76776], Nannizzia gypsea (species) [taxon 63402], Microsporum canis (species) [taxon 63405], Malassezia furfur (Pityriasis (Tinea) versicolor infection agent, species) [taxon 55194], Malassezia globosa (species) [taxon 76773], Athletes (genus) [taxon 1337349], Pseudomonas aeruginosa (species) [taxon 287], Corynebacterium pseudodiphtheriticum (species) [taxon 37637], Trichophyton rubrum (species) [taxon 5551], Enterococcus faecalis (species) [taxon 1351], Mucor plumbeus (species) [taxon 97098], Lucilia sericata (common green bottle fly, species) [taxon 13632], Leiurus quinquestriatus (Egyptian scorpion, species) [taxon 6883], Candida albicans (species) [taxon 5476], Fusarium oxysporum (species) [taxon 5507], Staphylococcus aureus (species) [taxon 1280], Epidermophyton floccosum (species) [taxon 34391], Harmonia axyridis (species) [taxon 115357], Aquarana catesbeiana (American bullfrog, species) [taxon 8400], Malassezia sympodialis (species) [taxon 76777], Trichophyton mentagrophytes (species) [taxon 523103], Escherichia coli (E. coli, species) [taxon 562]
- **Mutations:** L-to-D, A12-C
- **Cell lines:** NRC-16 — Homo sapiens (Human), Renal cell carcinoma, Cancer cell line (CVCL_WI00), COS7 — Chlorocebus aethiops (Green monkey), Transformed cell line (CVCL_0224), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4619455/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC4619455/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC4619455/full.md

---
Source: https://tomesphere.com/paper/PMC4619455